ACM
TMO icon

Arvin Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Arvin Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6M Sell
57,017
-54,680
-49% -$26.2M 3.73% 7
2026
Q1 		$54.9M Buy
111,697
+43,897
+65% +$23.8M 6.7% 3
2025
Q4 		$39.3M Sell
67,800
-14,670
-18% -$8.3M 7.4% 3
2025
Q3 		$40M Buy
82,470
+30,503
+59% +$14.2M 7.22% 2
2025
Q2 		$21.1M Buy
+51,967
New +$21.7M 4.31% 6
2024
Q1 		– Sell
-6,549
Closed -$3.48M – 37
2023
Q4 		$3.48M Buy
+6,549
New +$3.17M 1.53% 23

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Arvin Capital Management's TMO Position: Q2 2026 in Review

Arvin Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 49% in Q2 2026, selling an estimated $26.2M and leaving 57,017 shares worth $28.6M. The position accounts for 3.73% of the portfolio, ranked #7.

Arvin Capital Management first reported a position in TMO in Q4 2023 and has held it in 6 quarters since. The position peaked at $54.9M in Q1 2026. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Arvin Capital Management held 57,017 shares of Thermo Fisher Scientific worth $28.6M as of Q2 2026.
  • Arvin Capital Management sold 54,680 Thermo Fisher Scientific shares in Q2 2026, an estimated $26.2M.
  • Thermo Fisher Scientific made up 3.73% of Arvin Capital Management's portfolio in Q2 2026, its #7 holding.
  • Arvin Capital Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 6 quarters since.
  • Arvin Capital Management's Thermo Fisher Scientific position peaked at $54.9M in Q1 2026.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Arvin Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.